These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer. Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262 [TBL] [Abstract][Full Text] [Related]
4. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. Chen JL; Stewart-Jones G; Bossi G; Lissin NM; Wooldridge L; Choi EM; Held G; Dunbar PR; Esnouf RM; Sami M; Boulter JM; Rizkallah P; Renner C; Sewell A; van der Merwe PA; Jakobsen BK; Griffiths G; Jones EY; Cerundolo V J Exp Med; 2005 Apr; 201(8):1243-55. PubMed ID: 15837811 [TBL] [Abstract][Full Text] [Related]
6. An HLA-A2 polyepitope vaccine for melanoma immunotherapy. Mateo L; Gardner J; Chen Q; Schmidt C; Down M; Elliott SL; Pye SJ; Firat H; Lemonnier FA; Cebon J; Suhrbier A J Immunol; 1999 Oct; 163(7):4058-63. PubMed ID: 10491010 [TBL] [Abstract][Full Text] [Related]
7. Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2). Yoshimura S; Tsunoda T; Osawa R; Harada M; Watanabe T; Hikichi T; Katsuda M; Miyazawa M; Tani M; Iwahashi M; Takeda K; Katagiri T; Nakamura Y; Yamaue H PLoS One; 2014; 9(1):e85267. PubMed ID: 24416375 [TBL] [Abstract][Full Text] [Related]
8. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response. Kissick HT; Sanda MG; Dunn LK; Arredouani MS PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990 [TBL] [Abstract][Full Text] [Related]
9. The use of HLA class I tetramers to design a vaccination strategy for melanoma patients. Palmowski M; Salio M; Dunbar RP; Cerundolo V Immunol Rev; 2002 Oct; 188():155-63. PubMed ID: 12445289 [TBL] [Abstract][Full Text] [Related]
10. A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses. Sun W; Shi J; Wu J; Zhang J; Chen H; Li Y; Liu S; Wu Y; Tian Z; Cao X; Li N Cell Mol Immunol; 2018 Aug; 15(8):768-781. PubMed ID: 29375131 [TBL] [Abstract][Full Text] [Related]
11. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734 [TBL] [Abstract][Full Text] [Related]
12. Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells. Smith HA; McNeel DG J Immunother; 2011 Oct; 34(8):569-80. PubMed ID: 21904219 [TBL] [Abstract][Full Text] [Related]
13. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. Rice J; Dunn S; Piper K; Buchan SL; Moss PA; Stevenson FK Cancer Res; 2006 May; 66(10):5436-42. PubMed ID: 16707472 [TBL] [Abstract][Full Text] [Related]